4:12 PM Abstract No. 30 Supereselective Y90 radioembolization: treating beyond threshold doses.

On imaging follow-up, 22 lesions demonstrated complete response (96%), with 1 lesion demonstrating stable disease (4%). Superselective Y90 radioembolization of small liver volumes with substantially higher doses than previously reported is safe with favorable response rates. [Extracted from the article]